default author photo

Stephen Baker

University of Cambridge - Department of Medicine

United States

SCHOLARLY PAPERS

2

DOWNLOADS

149

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Prospective Study of Risk Factors Associated with Seroprevalence of SARS-CoV-2 Antibodies in Healthcare Workers at a Large UK Teaching Hospital

Number of pages: 33 Posted: 01 Dec 2020
NHS Foundation Trust - Cambridge University Hospitals, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge - Cambridge Institute for Medical Research, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, NIHR Cambridge Clinical Research Facility, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge School of Clinical Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, Independent, Government of the United Kingdom - Public Health England, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge - Division of Virology and University of Cambridge - Department of Medicine
Downloads 90 (747,755)

Abstract:

Loading...

SARS-CoV-2, COVID-19, sero-epidemiology, healthcare workers, risk factor analysis

2.

Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19

Number of pages: 105 Posted: 29 Dec 2020
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, University of Cambridge - Cambridge Institute for Medical Research, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 59 (970,490)

Abstract:

Loading...